Attached files
| file | filename |
|---|---|
| EX-31.1 - SECTION 302 CEO CERTIFICATION - SCOLR Pharma, Inc. | d239106dex311.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - SCOLR Pharma, Inc. | d239106dex312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SCOLR Pharma, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - SCOLR Pharma, Inc. | d239106d10q.htm |
| EX-32.2 - SECTION 906 CFO CERTIFICATION - SCOLR Pharma, Inc. | d239106dex322.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of SCOLR Pharma, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen J. Turner, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| By: | /s/ STEPHEN J. TURNER | |
| Stephen J. Turner | ||
| President and Chief Executive Officer | ||
| SCOLR Pharma, Inc. |
Date: November 10, 2011